As per a report published by the National Center for Biotechnology Information (NCBI) in the year 2014, nearly US $ 1.9 billion is estimated to be invested on medical application of 3D printing in coming decade. Such huge investment inflow is likely to bolster the market growth.

Incorporation of 3D printing in healthcare has provided wide prospect for personalized patient care. The technology enables medical professionals to define the complexity of any organs and treat the associated condition as per the requirement. Although, the market is in its nascent stage, ongoing research and development in the 3D-printing technology is likely to accelerate the market in coming years.

As per a report published by the National Center for Biotechnology Information (NCBI) in the year 2014, nearly US $ 1.9 billion is estimated to be invested on medical application of 3D printing in coming decade. Such huge investment inflow is likely to bolster the market growth.
Further, growing trend of implants customization for surgical procedures is pushing the horizon of healthcare 3D printing market. The 3D printing technology is enabling customization of dental implants, contact lenses, hearing aids, and prosthesis for individuals. With the help of personalized digital data, medical professionals are trying to create personalized blueprint of organs for individuals.
Moreover, 3D printing is enabling production of ears, jaw bone, cell cultures, stem cells, vascular networks, tissues, blood vessels, and organs. Technological advances in healthcare 3D printing and integration of advanced medical devices from the field of tissue engineering and bio printing are, conjointly, resulting in the growth of 3D printing market. 333
Growing Geriatric Population Underpins Market Expansion
Meanwhile, rising geriatric population across the globe is paving way for expansion of the healthcare 3D printing market worldwide. Age is counted among major risk factors for development of various health conditions such as cardiovascular, hearing issue, orthopedic, oral concerns, and others. As a result, demand for healthcare is exponentially increasing.
The target market is also witnessing demand from pharmaceutical sector. Use of poly pill for treatment of various disease is bolstering healthcare 3D printing market growth trajectory. Health care 3D printing technology is extensively being implemented in new dosage forms and drug delivery devices.
On the other hand, lack of skilled professionals and high installation cost of 3D printing software might downturn growth trajectory of the healthcare 3D printing market. As per a report provided by the Society of Manufacturing Engineering, out of 10 manufacturing companies, 9 are not able to find expert workers. Approximately 54% companies have yet found a way out to address shortage of skilled labor.
Innovations and Developments Aiding Key Players Sustain Position in Global Market
Some of the prominent business players operating in the global healthcare 3D printing market are 3D Biotek, Luxexcel, Aspect Biosystems, Aprecia Pharmaceuticals, regenHU, 3D Bioprinting Solutions, BioBots, Oceanz, TeVido BioDevices, Bio 3D Technologies, Cyfuse Biomedical, Digilab, 3Dynamics Systems, Envision TEC, Materialise NV, Nano3D Biosciences, Organovo Holdings, Renishaw, Solidscape, 3D systems, and Stratasys.
These players are undertaking organic and inorganic growth strategies to strengthen their foothold in the global healthcare 3D printing landscape. Some of the aforementioned companies are consistently developing innovative technologies.
For example, in March 2017, 3D systems launched its first modular, scalable, and integrated additive printing manufacturing machines. The machine would enhance durability of the product, and at the same time provides sustainable environment for manufacturing process. Meanwhile, to maintain the competitive edge, few other players have also offered to provide extended customized services to their customer.
Similarly, in October 2016, Organavo developed 3D bio-printed human liver. It is a prominent preclinical development in related to therapeutic tissue for animal models. The preclinical innovation showcase engraftment, vascularization, and sustained functionalities of the bio-printed liver tissues.
Such developments by manufacturing companies are aiding them to mark their position in the global market. At the same time, it is bolstering healthcare 3D market.